Vikas Majithia, MD
Rheumatology · Jackson, MSNPI 1073540266
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $96,238 of the $123,147 with a category attached, or 78.1%. 25 manufacturers reported payments, led by Novartis at 47.9% of the total. Reporting peaked in 2019 at $39,107 and has fallen 73.3% since, to $10,459 in 2025. Among rheumatology clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 311 payments — averaging $395.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$59K
- Novartis Pharma AG$18K
- UCB, Inc.$15K
- Lilly USA, LLC$7K
- AbbVie$6K
- E.r. Squibb & Sons, L.L.C.$5K
- plus $12K from 19 others
Across 44 payments — averaging $29,842 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$859K
- E.r. Squibb & Sons, L.L.C.$313K
- Novartis$54K
- GSK$28K
- Aurinia Pharma U.S., Inc.$19K
- EMD Serono, Inc.$19K
- plus $20K from 3 others
What the payments were for
- Consulting fees$96,23878%
- Speaking & faculty fees$3,6623%
- Travel & lodging$15,67513%
- Food & beverage$7,4856%
- Education$870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 52 | $59,013 |
| Novartis Pharma AG | 8 | $18,484 |
| UCB, Inc. | 25 | $15,432 |
| Lilly USA, LLC | 16 | $6,758 |
| AbbVie | 54 | $6,342 |
| E.r. Squibb & Sons, L.L.C. | 5 | $5,340 |
| Boehringer Ingelheim | 6 | $3,954 |
| GSK | 23 | $3,094 |
| Fresenius Kabi USA, LLC | 1 | $1,440 |
| Amgen | 45 | $1,052 |
| Aurinia Pharma U.S., Inc. | 9 | $458 |
| Johnson & Johnson | 23 | $450 |
| Bristol Myers Squibb | 7 | $363 |
| AstraZeneca | 4 | $276 |
| Radius Health, Inc. | 9 | $191 |
| Sanofi | 3 | $162 |
| Pfizer | 10 | $135 |
| Genentech USA, Inc. | 4 | $61 |
| Janssen Scientific Affairs, LLC | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Sobi, Inc | 1 | $19 |
| Genentech, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Actelion Pharmaceuticals US, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$123,147 in reported general payments places this provider in the 95th percentile of 44 rheumatology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 20 | $147,661 |
| Hydroxychloroquine Sulfate | 65 | $3,151 |
| MethotrexateMethotrexate Sodium | 52 | $919 |
| Prednisone | 120 | $857 |
| Allopurinol | 14 | $146 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Jackson
- Neal ShparagoJackson$39K
- Teresa CroutJackson$16K
- Amanda FowlerJackson$13K
- Robert McMurrayJackson$12K
- Martha MagnusonJackson$3K
- Linda RockholdJackson$2K
- Nirupa MohandasJackson$1K
- Maneesh MannemJackson$1K
- Hanan IbrahimJackson$882
- Lisa MaherJackson$644
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.